Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on vaccine-type invasive pneumococcal disease among young children.
about
Impacts of the 13-Valent Pneumococcal Conjugate Vaccine in ChildrenMethods for a systematic review of pneumococcal conjugate vaccine dosing schedulesThe potential impact of pneumococcal conjugate vaccine in Africa: Considerations and early lessons learned from the South African experienceEffects of Vaccination with 10-Valent Pneumococcal Non-Typeable Haemophilus influenza Protein D Conjugate Vaccine (PHiD-CV) on the Nasopharyngeal Microbiome of Kenyan Toddlers.The influence of Streptococcus pneumoniae nasopharyngeal colonization on the clinical outcome of the respiratory tract infections in preschool children.10-valent pneumococcal non-typeable Haemophilus influenzae protein-D conjugate vaccine (PHiD-CV) induces memory B cell responses in healthy Kenyan toddlers.Etiology and antimicrobial susceptibility of middle ear fluid pathogens in Costa Rican children with otitis media before and after the introduction of the 7-valent pneumococcal conjugate vaccine in the National Immunization Program: acute otitis medThe Clinical Effectiveness of Pneumococcal Conjugate Vaccines: A Systematic Review and Meta-analysis of Randomized Controlled Trials.Anatomical site-specific contributions of pneumococcal virulence determinants.Evaluating the impact of PCV-10 on invasive pneumococcal disease in Brazil: A time-series analysisSystematic review of the effect of pneumococcal conjugate vaccine dosing schedules on immunogenicity.Dosing schedules for pneumococcal conjugate vaccine: considerations for policy makersSystematic review of the effect of pneumococcal conjugate vaccine dosing schedules on vaccine-type nasopharyngeal carriage.Systematic review of the indirect effect of pneumococcal conjugate vaccine dosing schedules on pneumococcal disease and colonization.Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on prevention of pneumonia.The differential impact of coadministered vaccines, geographic region, vaccine product and other covariates on pneumococcal conjugate vaccine immunogenicity.Cost-effectiveness of 13-valent pneumococcal conjugate vaccination in Mongolia.Antibody persistence and immunologic memory in children vaccinated with 4 doses of pneumococcal conjugate vaccines: Results from 2 long-term follow-up studies.The impact of 10-valent and 13-valent pneumococcal conjugate vaccines on serotype 19A invasive pneumococcal disease.Immunization with 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) according to different schedules in infants in South Africa: a phase III trial.Preventing non bacteremic pneumococcal pneumonia in older adults: historical background and considerations for choosing between PCV13 and PPV23.New opportunities for managing acute and chronic lung infections.Impact of pneumococcal conjugate vaccine on pediatric tympanostomy tube insertion in partial immunized population.Determining the pneumococcal conjugate vaccine coverage required for indirect protection against vaccine-type pneumococcal carriage in low and middle-income countries: a protocol for a prospective observational study.Evaluation of different infant vaccination schedules incorporating pneumococcal vaccination (The Vietnam Pneumococcal Project): protocol of a randomised controlled trial.
P2860
Q26782280-BAEDDB64-525D-44FA-B229-E612CD931F77Q26851993-EC130DCE-B9BD-4571-9999-A7F3F2FEDDF4Q28088507-063320BC-5E9E-47BC-85C8-947B4D74611BQ35666118-00F920B9-F72B-432D-861F-0149BDE8A0D2Q35794178-B2F9CD66-2E2D-4C4E-99FF-324DB60DB46EQ35893171-8296DD55-D14A-499A-A4F8-BD5F5E121B24Q36151434-74301873-144E-4372-ACCD-CD2E01404950Q36713715-A12D6EC6-5380-44E8-88F2-76D8CE8B21A5Q37252799-182C2509-B8FD-4BE8-9E21-C24834AF3D20Q37309294-37DA1C06-69D1-4FC5-9CB1-CE1C395C2F37Q37613613-3E5D2E63-4511-437F-846B-6CA2E3FBEC95Q37613616-08E233CE-F610-4EBF-A815-DBCF82E2C20FQ37613922-F0680B20-B74D-4C6B-B769-7D7FB312E2F4Q37613925-9063FFE2-645B-4BA9-8FDA-8B562B025B6AQ37621054-7A041BBB-B1A5-4A44-8135-FF00F5417124Q37621061-CA2CB95C-5471-4289-AD36-F841AC888DB2Q37631215-C14AB07B-DBA2-4CEE-A6D5-28C0EA53A44EQ37713768-204C0693-7676-439C-BE8A-4DD7D9169332Q38569828-29D5EF94-3D34-45BB-ADC9-C2E06C1D86AAQ38829068-FED3CF21-6C5D-46C6-82B2-C18492545FFAQ42738528-F4E054B7-79FB-460B-9E66-8959407EB044Q47734944-E61091B8-6594-4D8D-BD4B-B1EA67455FE5Q51363718-2F42FF10-CA85-41A9-9484-9C3EB7C49FE0Q54206312-E627D8D9-0C28-4E31-A0E1-4224BB9BE928Q55313306-C8118F9B-91FC-4D1A-BEBD-96859C3E93B6
P2860
Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on vaccine-type invasive pneumococcal disease among young children.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Systematic review of the effec ...... disease among young children.
@en
Systematic review of the effec ...... disease among young children.
@nl
type
label
Systematic review of the effec ...... disease among young children.
@en
Systematic review of the effec ...... disease among young children.
@nl
prefLabel
Systematic review of the effec ...... disease among young children.
@en
Systematic review of the effec ...... disease among young children.
@nl
P2093
P2860
P50
P1476
Systematic review of the effec ...... disease among young children.
@en
P2093
Cynthia G Whitney
Jennifer D Loo
Jennifer Kirk
Katherine E Fleming-Dutra
Laura Conklin
P2860
P304
P356
10.1097/INF.0000000000000078
P478
33 Suppl 2
P577
2014-01-01T00:00:00Z